On February 15, 2021 BioTheryX, Inc., a clinical-stage company focused on degrading proteins to create life-saving medicines, reported that the company will participate virtually in the following scientific and investor events (Press release, BioTheryX, FEB 15, 2021, View Source [SID1234575080]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Targeted Protein Degradation & PROTAC Symposium
Tuesday, February 16, 2021, 16:30 GMT
Aparajita Hoskote Chourasia, Ph.D., Senior Director of Biology, will give a presentation entitled, "Developing Novel Cereblon-Directed PHMs as First-in-Class Targeted Protein Degradation Therapies".
North American Protein Degradation Congress
Tuesday, February 23, 2021, 3:00 pm ET
Leah Fung, VP, Medicinal Chemistry, will give a presentation entitled, "BioTheryX is Leveraging Novel Cereblon-Directed Molecular Glues to Discover First-in-Class TPD Therapies for Oncology".
LifeSci Partners Precision Oncology Day
Wednesday, February 17, 2021, 1:00 PM ET
Rob Williamson, President and CEO, will present an overview on the company’s targeted protein degradation platform and the management team will participate in 1x1s with investors.
BMO BioPharma Spotlight Series: Targeted Protein Degradation and Other Next Gen Protein Technologies
Thursday, February 18, 2021, 10:30 AM ET
Rob Williamson, President and CEO, will participate in a panel entitled "Ligating Competitors for Collaboration in the Protein Degradation Space", moderated by BMO analysts Matt Luchini and Nick Lenard.
Additional panel participants include Ian Taylor, CSO, Arvinas; Stew Fisher, CSO, C4 Therapeutics; and Jared Gollob, CMO, Kymera. In addition to the panel, the BioTheryX management team will also participate in 1x1s with investors during the event.
2021 SVB Leerink Global Healthcare Conference
Tuesday, February 23, 2021
The BioTheryX management team will participate in 1x1s with investors.